Q69-64511-61832
3 vaccinations
3 coded responses
22 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 936 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Moderna
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-24
- 2021-04-04
- 2021-04-09
-
2021-04-17
Dose 2 — Moderna
-
2021-04-17
Health check-in — day 0, dose 2Feeling: Good · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-23
- 2021-05-03
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-07-19
-
2021-10-16
Survey response — 6 months, dose 2MedDRA: Malaise, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid symptoms but repeated negative testsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Dose 3 — Moderna
-
2022-04-18
Survey response — 12 months, dose 2MedDRA: Anaemia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Severe Anemia · Healthcare visit (other): Infusion centerMedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-17
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-12-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Moderna | |
| 2 | 2021-04-17 | Moderna | |
| 3 | 2021-12-17 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: Covid symptoms but repeated negative tests
Release 11 — 12 months, dose 2
Release 12 — 6 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Anaemia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release